Jelacic TM - Search Results

1

Human Innate Immune Cells Respond Differentially to Poly-γ-Glutamic Acid Polymers from Bacillus anthracis and Nonpathogenic Bacillus Species.

Jelacic TM, Ribot WJ, Chua J, Boyer AE, Woolfitt AR, Barr JR, Friedlander AM. Jelacic TM, et al. J Immunol. 2020 Mar 1;204(5):1263-1273. doi: 10.4049/jimmunol.1901066. Epub 2020 Jan 13. J Immunol. 2020. PMID: 31932496 Free PMC article.

2

Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells.

Jelacic TM, Chabot DJ, Bozue JA, Tobery SA, West MW, Moody K, Yang D, Oppenheim JJ, Friedlander AM. Jelacic TM, et al. Infect Immun. 2014 Aug;82(8):3405-16. doi: 10.1128/IAI.01857-14. Epub 2014 Jun 2. Infect Immun. 2014. PMID: 24891109 Free PMC article.

3

Poly-γ-Glutamic Acid Encapsulation of Bacillus anthracis Inhibits Human Dendritic Cell Responses.

Jelacic TM, Ribot WJ, Tobery SA, Chabot DJ, Friedlander AM. Jelacic TM, et al. Immunohorizons. 2021 Feb 9;5(2):81-89. doi: 10.4049/immunohorizons.2100004. Immunohorizons. 2021. PMID: 33563659 Free article.

4

The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides.

O'Brien DK, Ribot WJ, Chabot DJ, Scorpio A, Tobery SA, Jelacic TM, Wu Z, Friedlander AM. O'Brien DK, et al. Among authors: jelacic tm. PLoS Pathog. 2022 Sep 29;18(9):e1010851. doi: 10.1371/journal.ppat.1010851. eCollection 2022 Sep. PLoS Pathog. 2022. PMID: 36174087 Free PMC article.

5

Engineering an Fc-Fusion of a Capsule Degrading Enzyme for the Treatment of Anthrax.

Matharoo K, Chua J, Park JR, Ingavale S, Jelacic TM, Jurkouich KM, Compton JR, Meinig JM, Chabot D, Friedlander AM, Legler PM. Matharoo K, et al. Among authors: jelacic tm. ACS Infect Dis. 2022 Oct 14;8(10):2133-2148. doi: 10.1021/acsinfecdis.2c00227. Epub 2022 Sep 14. ACS Infect Dis. 2022. PMID: 36102590

6

Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk.

Nishigaki K, Hanson C, Jelacic T, Thompson D, Ruscetti S. Nishigaki K, et al. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15488-93. doi: 10.1073/pnas.0506570102. Epub 2005 Oct 13. Proc Natl Acad Sci U S A. 2005. PMID: 16223879 Free PMC article.

7

The tyrosine kinase sf-Stk and its downstream signals are required for maintenance of friend spleen focus-forming virus-induced fibroblast transformation.

Jelacic TM, Thompson D, Hanson C, Cmarik JL, Nishigaki K, Ruscetti S. Jelacic TM, et al. J Virol. 2008 Jan;82(1):419-27. doi: 10.1128/JVI.01349-07. Epub 2007 Oct 24. J Virol. 2008. PMID: 17959667 Free PMC article.

8

Normal and oncogenic forms of the receptor tyrosine kinase kit.

Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R. Lennartsson J, et al. Stem Cells. 2005;23(1):16-43. doi: 10.1634/stemcells.2004-0117. Stem Cells. 2005. PMID: 15625120 Review.

9

PKCdelta plays opposite roles in growth mediated by wild-type Kit and an oncogenic Kit mutant.

Jelacic T, Linnekin D. Jelacic T, et al. Blood. 2005 Mar 1;105(5):1923-9. doi: 10.1182/blood-2004-04-1450. Epub 2004 Nov 12. Blood. 2005. PMID: 15542581 Free article.

10

Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3.

Jelacic TM, Kennedy ME, Wickman K, Clapham DE. Jelacic TM, et al. J Biol Chem. 2000 Nov 17;275(46):36211-6. doi: 10.1074/jbc.M007087200. J Biol Chem. 2000. PMID: 10956667 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters